These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 21242887)

  • 1. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.
    Karn J
    Curr Opin HIV AIDS; 2011 Jan; 6(1):4-11. PubMed ID: 21242887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of HIV latency by epigenetic and non-epigenetic mechanisms.
    Mbonye U; Karn J
    Curr HIV Res; 2011 Dec; 9(8):554-67. PubMed ID: 22211660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway.
    Kim YK; Mbonye U; Hokello J; Karn J
    J Mol Biol; 2011 Jul; 410(5):896-916. PubMed ID: 21763495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.
    Mbonye U; Karn J
    Virology; 2014 Apr; 454-455():328-39. PubMed ID: 24565118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell biology of HIV-1 latency and rebound.
    Mbonye U; Karn J
    Retrovirology; 2024 Apr; 21(1):6. PubMed ID: 38580979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
    Li Z; Guo J; Wu Y; Zhou Q
    Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
    Hokello J; Sharma AL; Tyagi M
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
    Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
    J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency.
    Pearson R; Kim YK; Hokello J; Lassen K; Friedman J; Tyagi M; Karn J
    J Virol; 2008 Dec; 82(24):12291-303. PubMed ID: 18829756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.
    Wang C; Yang S; Lu H; You H; Ni M; Shan W; Lin T; Gao X; Chen H; Zhou Q; Xue Y
    PLoS One; 2015; 10(11):e0142739. PubMed ID: 26569506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 latency in actively dividing human T cell lines.
    Jeeninga RE; Westerhout EM; van Gerven ML; Berkhout B
    Retrovirology; 2008 Apr; 5():37. PubMed ID: 18439275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Didehydro-Cortistatin A: a new player in HIV-therapy?
    Mousseau G; Valente ST
    Expert Rev Anti Infect Ther; 2016; 14(2):145-8. PubMed ID: 26581953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.